EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Age-Dependent Effect of Myostatin Blockade in the mdx Mouse Model of Duchenne Muscular Dystrophy (DMD)

Sasha Bogdanovich iD, Emidio E Pistilli, Tejvir S Khurana

Muscles · 20.08.2026 · 5 (3) · 58

DOI: 10.3390/muscles5030058 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Muscles, online erschienen am 20.08.2026. Verfasst von Sasha Bogdanovich und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Pennsylvania Muscle Institute, Perelman School of Medicine, University of Pennsylvania, 415 Curie Boulevard, Philadelphia, …. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wyeth Pharmaceuticals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myostatin (GDF8) is a member of the transforming growth factor-β (TGF-β) superfamily. Myostatin gene mutations or inhibition of the Myostatin/Activin pathway results in increased skeletal muscle mass, demonstrating its role as a negative regulator of skeletal muscle. Myostatin blockade is a promising strategy for increasing muscle mass in myopathies such as Duchenne Muscular Dystrophy (DMD); however, it faces considerable challenges in clinical translation, in part due to the progressive nature of the disease. Here we tested the ability of JA16 monoclonal antibody-mediated myostatin blockade to improve the dystrophic phenotype in newborn mdx mice (an animal model of DMD). Myostatin inhibition led to significant increases in muscle size, fiber number and cross-sectional area along with increased absolute force alongside reduced post-eccentric contraction force drop and reduced serum creatine kinase. We used the Multiparametric Muscle Improvement Score (MMIS) to objectively quantitate benefits in this preclinical study and determined that the magnitude of improvements exceeded those reported using the exact same intervention in older mdx mice treated for the same duration. This study demonstrates an age-dependent aspect of this intervention and suggests that earlier interventions may provide greater therapeutic benefits.

Schlagwörter

Stichwörter der Autor:innen

ActivinDuchenne Muscular DystrophyMMISMultiparametric Muscle Improvement Scoremdxmyostatin blockadeneonatal improvementyoung

Autor:innen und Institutionen

  • Department of Physiology, Pennsylvania Muscle Institute, Perelman School of Medicine, University of Pennsylvania, 415 Curie Boulevard, Philadelphia, PA 19104, USA.
  • School of Medicine, West Virginia University, Morgantown, WV 26506, USA.

ORCID-Profile: Sasha Bogdanovich

Förderung

  • Wyeth Pharmaceuticals

Zitieren

APA

Bogdanovich, S., Pistilli, E. E., & Khurana, T. S. (2026). Age-Dependent Effect of Myostatin Blockade in the mdx Mouse Model of Duchenne Muscular Dystrophy (DMD). Muscles, 5(3), 58. https://doi.org/10.3390/muscles5030058

Vancouver

Bogdanovich S, Pistilli EE, Khurana TS. Age-Dependent Effect of Myostatin Blockade in the mdx Mouse Model of Duchenne Muscular Dystrophy (DMD). Muscles. 2026;5(3):58. doi:10.3390/muscles5030058

BibTeX
@article{Bogdanovich2026,
  author = {Bogdanovich, Sasha and Pistilli, Emidio E and Khurana, Tejvir S},
  title = {Age-Dependent Effect of Myostatin Blockade in the mdx Mouse Model of Duchenne Muscular Dystrophy (DMD)},
  journal = {Muscles},
  year = {2026},
  volume = {5},
  number = {3},
  pages = {58},
  doi = {10.3390/muscles5030058}
}
Kostenlos starten →